Empiric tenecteplase is associated with increased return of spontaneous circulation and short term survival in cardiac arrest patients unresponsive to standard interventions

Resuscitation

Volumn 69, Issue 3, 2006, Pages 399-406

  Bozeman, William P ^a   Kleiner, Douglas M ^b   Ferguson, Kevin L ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac arrest; Resuscitation; Thrombolysis

Indexed keywords

TENECTEPLASE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART ARREST; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; STANDARDIZATION; TREATMENT OUTCOME;

ADVANCED CARDIAC LIFE SUPPORT; BLOOD CIRCULATION; EMERGENCY MEDICAL SERVICES; FEMALE; FIBRINOLYTIC AGENTS; HEART ARREST; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33646876835     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2005.09.027     Document Type: Article

References (34)

1. Zheng Z.J., et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation 104 18 (2001) 2158-2163
2. Zipes D.P., and Wellens H.J. Sudden cardiac death. Circulation 98 21 (1998) 2334-2351
3. Engelstein E., and Zipes D.P. Sudden cardiac death. In: Alexander R., Schlant R., and Fuster V. (Eds). Hurst's The Heart Arteries and Veins vol. 1 (1998), McGraw Hill Health Professions Division 1081-1112
4. Escobedo L.G., and Zack M.M. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation 93 11 (1996) 2033-2036
5. Stiell I.G., et al. Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J Med 351 7 (2004) 647-656
6. Nichol G., et al. Effectiveness of emergency medical services for victims of out-of-hospital cardiac arrest: a metaanalysis. Ann Emerg Med 27 6 (1996) 700-710
7. Callaway C.W. Improving neurologic outcomes after out-of-hospital cardiac arrest. Prehosp Emerg Care 1 1 (1997) 45-57
8. Spaulding C.M., et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 336 23 (1997) 1629-1633
9. Engdahl J., et al. The epidemiology of out-of-hospital 'sudden' cardiac arrest. Resuscitation 52 3 (2002) 235-245
10. Courtney D.M., et al. Pulseless electrical activity with witnessed arrest as a predictor of sudden death from massive pulmonary embolism in outpatients. Resuscitation 49 3 (2001) 265-272
11. Gallerani M., et al. Sudden death from pulmonary thromboembolism: chronobiological aspects. Eur Heart J 13 5 (1992) 661-665
12. Manfredini R., et al. Out-of-hospital sudden death referring to an emergency department. J Clin Epidemiol 49 8 (1996) 865-868
13. Kurkciyan I., et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med 160 10 (2000) 1529-1535
14. Cross S.J., et al. Safety of thrombolysis in association with cardiopulmonary resuscitation. BMJ 303 6812 (1991) 1242
15. Tenaglia A.N., et al. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation. Am J Cardiol 68 10 (1991) 1015-1019
16. Scholz K.H., et al. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am J Cardiol 69 8 (1992) 724-728
17. van Campen L.C., van Leeuwen G.R., and Verheugt F.W. Safety and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged out-of-hospital cardiopulmonary resuscitation. Am J Cardiol 73 13 (1994) 953-955
18. Spohr F., and Bottiger B.W. Safety of thrombolysis during cardiopulmonary resuscitation. Drug Saf 26 6 (2003) 367-379
19. Kurkciyan I., et al. Major bleeding complications after cardiopulmonary resuscitation: impact of thrombolytic treatment. J Intern Med 253 2 (2003) 128-135
20. Newman D.H., Greenwald I., and Callaway C.W. Cardiac arrest and the role of thrombolytic agents. Ann Emerg Med 35 5 (2000) 472-480
21. Ruiz-Bailen M., et al. Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation. Intensive Care Med 27 6 (2001) 1050-1057
22. Bottiger B.W., et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 357 9268 (2001) 1583-1585
23. Lederer W., et al. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 50 1 (2001) 71-76
24. Schreiber W., et al. Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. Resuscitation 52 1 (2002) 63-69
25. Lederer W., et al. Long-term survival and neurological outcome of patients who received recombinant tissue plasminogen activator during out-of-hospital cardiac arrest. Resuscitation 61 2 (2004) 123-129
26. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Assessment of the safety and efficacy of a new thrombolytic investigators. Lancet 1999;354(9180): 716-22.
27. Cummins R.O., et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation 84 2 (1991) 960-975
28. Bottiger B.W., et al. Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 92 9 (1995) 2572-2578
29. Johansson J., et al. Antithrombin reduction after experimental cardiopulmonary resuscitation. Resuscitation 59 2 (2003) 235-242
30. Gando S., et al. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost 77 2 (1997) 278-282
31. Bottiger B.W., et al. Marked activation of complement and leukocytes and an increase in the concentrations of soluble endothelial adhesion molecules during cardiopulmonary resuscitation and early reperfusion after cardiac arrest in humans. Crit Care Med 30 11 (2002) 2473-2480
32. Fischer M., et al. Thrombolysis using plasminogen activator and heparin reduces cerebral no-reflow after resuscitation from cardiac arrest: an experimental study in the cat. Intensive Care Med 22 11 (1996) 1214-1223
33. Fatovich D.M., Dobb G.J., and Clugston R.A. A pilot randomised trial of thrombolysis in cardiac arrest (the TICA trial). Resuscitation 61 3 (2004) 309-313
34. Bottiger B.W., Padosch S.A., and Wenzel V. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity. N Engl J Med 347 16 (2002) 1281-1282 author reply 1281-2